CJC-1295 No DAC (5mg)
CJC-1295 (No DAC) is a GHRH analog studied to increase natural growth hormone release in short bursts.
Research Summary: Growth hormone-releasing hormone analogue studied for short-acting GH and IGF-1 elevation in clinical and preclinical settings.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
CJC-1295 With DAC (2mg)
CJC-1295 with DAC offers longer-lasting GH stimulation, ideal for extended anabolic research protocols.
Research Summary: Long-acting version of CJC-1295 designed to prolong GH elevation. Researched in sustained-release hormone protocols.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
Ipamorelin (10mg)
Ipamorelin is a selective GH secretagogue that promotes growth hormone release without increasing cortisol.
Research Summary: Ghrelin mimetic studied for its selective growth hormone secretagogue activity without elevating cortisol or prolactin.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
Tesamorelin (10mg)
Tesamorelin is used in clinical research for its role in reducing visceral fat and enhancing GH secretion.
Research Summary: GHRH analogue researched for reduction in visceral adipose tissue and IGF-1 elevation in metabolic conditions.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.








